New Journey(SZ:002219)2022-12-06 09:48Group 1: Financial Performance - The company experienced significant growth in both revenue and net profit in the first half of 2016, attributed to the expansion of the consolidated financial statement scope and improved internal management practices [2]. - The company invested CNY 177 million in Chongzhou Second Hospital to enhance its construction, leveraging its strong local brand and reputation [2]. Group 2: Hospital Operations - Ganxi Tumor Hospital has officially commenced operations and is building a solid foundation in brand, business development, and talent, while collaborating with Jiangxi Provincial Tumor Hospital to enhance its local influence [2]. - The company focuses on selecting hospitals that are either restructured or can be restructured, prioritizing those with a minimum of secondary class and clear specialty advantages, as well as a concentrated regional population [2]. Group 3: Future Developments - The company is planning to construct hospitals primarily focused on oncology and high-end obstetrics, including Dalian International Tumor Hospital and Mianyang Aibeier Obstetrics Hospital, while integrating existing hospital teams and attracting external talent [2]. - The company has established a centralized procurement center to enhance its bargaining power and achieve cost reduction and efficiency improvements [3].